Carol Prives

Last updated
Carol Prives
EducationBSc McGill University, Canada

PhD McGill University, Canada

Honorary Doctor of Sciences McGill University, Canada
Alma mater
Known forThe characterization of p53, an important tumour suppressor protein frequently mutated in cancer.
AwardsNIH MERIT Award (1996)

Rosalind E. Franklin Award for Women in Science, National Cancer Institute (2009)

Contents

Paul Janssen Prize in Biotechnology and Medicine (2010)

AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship (2011)
Scientific career
Institutions

Professor Carol L. Prives FRS is the Da Costa Professor of Biological Sciences at Columbia University. [1] She is known for her work in the characterisation of p53, an important tumor suppressor protein frequently mutated in cancer.

Education

Prives was educated in Canada, received her BSc and PhD [2] in 1966 [3] from McGill University, undertaking research in the lab of Juda Hirsch Quastel. [4] She pursued postdoctoral fellowships at Albert Einstein College of Medicine and the Weizmann Institute under the mentorship of Professor Michel Revel. after which she became a faculty member at the Weizmann Institute. [1] She received an honorary Doctor of Sciences degree from McGill University, her alma mater, on 29 May 2014 for her contributions to the understanding of p53. [5]

Research and career

In 1995, she was appointed as the Da Costa Professor of Biology at Columbia University. [3] She was the chair of the Department of Biological Sciences from 2000 to 2004. [6]

Her early interest in the SV40 DNA tumour virus as a model for eukaryotic gene expression and oncogenic transformation led her to the study of p53. [7] Since the late 1980s, her lab has focused on the p53 tumour suppressor gene, one of the most frequently mutated in human cancers.

Prives has served as chair of the Experimental Virology and the Cell and Molecular Pathology study sections of the National Institutes of Health. She has been a member of the Scientific Advisory Boards of the Dana–Farber Cancer Institute, the Memorial Sloan Kettering Cancer Center, the Massachusetts General Cancer Center, the National Cancer Institute, [1] and the Weizmann Institute. [6] She was a member of the board of directors of the American Association for Cancer Research from 2004 to 2007. She also served on the Life Sciences jury for the Infosys Prize in 2010.

She is a member of the editorial boards of Cell , [8] Oncogene [9] and the Proceedings of the National Academy of Sciences . [10]

Awards

Related Research Articles

<span class="mw-page-title-main">Alfred G. Knudson</span> American physician and geneticist

Alfred George Knudson, Jr. was an American physician and geneticist specializing in cancer genetics. Among his many contributions to the field was the formulation of the Knudson hypothesis in 1971, which explains the effects of mutation on carcinogenesis.

Karen Heather Vousden, CBE, FRS, FRSE, FMedSci is a British medical researcher. She is known for her work on the tumour suppressor protein, p53, and in particular her discovery of the important regulatory role of Mdm2, an attractive target for anti-cancer agents. From 2003 to 2016, she was the director of the Cancer Research UK Beatson Institute in Glasgow, UK, moving back to London in 2016 to take up the role of Chief Scientist at CRUK and Group Leader at the Francis Crick Institute.

Arnold Jay Levine, is an American molecular biologist. He was awarded the 1998 Louisa Gross Horwitz Prize for Biology or Biochemistry and was the first recipient of the Albany Medical Center Prize in Medicine and Biomedical Research in 2001 for his discovery of the tumor suppressor protein p53.

<span class="mw-page-title-main">Aviv Regev</span> Bioinformatician

Aviv Regev is a computational biologist and systems biologist and Executive Vice President and Head of Genentech Research and Early Development in Genentech/Roche. She is a core member at the Broad Institute of MIT and Harvard and professor at the Department of Biology of the Massachusetts Institute of Technology. Regev is a pioneer of single cell genomics and of computational and systems biology of gene regulatory circuits. She founded and leads the Human Cell Atlas project, together with Sarah Teichmann.

Peter K. Vogt is an American molecular biologist, virologist and geneticist. His research focuses on retroviruses and viral and cellular oncogenes.

<span class="mw-page-title-main">Jill Bargonetti</span> American professor at Hunter College

Jill Bargonetti is an American professor at the City University of New York with dual appointments at Hunter College and The Graduate Center. Her research is focused on tumor suppressor protein p53 and its role as an oncogene when it is mutated in breast cancer.

<span class="mw-page-title-main">Demetrios Spandidos</span> Greek virologist and cancer researcher (born 1947)

Demetrios A. Spandidos is a Greek virologist and cancer researcher. He is an emeritus professor at the University of Crete where he was professor of virology from 1989 till 2015. He is also the founder of Spandidos Publications and the editor-in-chief of all eight of its journals.

Luis F. Parada is a Colombian developmental biologist and neuroscientist who currently serves as Director of the Brain Tumor Center, Albert C. Foster Chair and American Cancer Society Research Professor at Memorial Sloan Kettering Cancer Center in New York City, New York.

<span class="mw-page-title-main">William Kaelin Jr.</span> American Nobel Laureate, Professor of Medicine at Harvard University

William G. Kaelin Jr. is an American Nobel laureate physician-scientist. He is a professor of medicine at Harvard University and the Dana–Farber Cancer Institute. His laboratory studies tumor suppressor proteins. In 2016, Kaelin received the Albert Lasker Award for Basic Medical Research and the AACR Princess Takamatsu Award. He also won the Nobel Prize in Physiology or Medicine in 2019 along with Peter J. Ratcliffe and Gregg L. Semenza.

<span class="mw-page-title-main">Scott W. Lowe</span> American geneticist

Scott William Lowe is Chair of the Cancer Biology and Genetics Program in the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. He is recognized for his research on the tumor suppressor gene, p53, which is mutated in nearly half of cancers.

Kevan Michael Shokat is an American chemical biologist. He is a Professor and chair in the Department of Cellular and Molecular Pharmacology at University of California, San Francisco, a professor in the Department of Chemistry at University of California, Berkeley, and an Investigator with the Howard Hughes Medical Institute.

Kenneth Wayne Kinzler is a professor of oncology, and director of the Ludwig Center at Johns Hopkins University at the Sidney Kimmel Comprehensive Cancer Center.

Sagar Sengupta is an Indian immunologist, cancer biologist and a scientist at the National Institute of Immunology, India. Known for his studies on tumor suppressor gene and oncogenes, Sengupta is an elected fellow of all the three major Indian science academies namely the National Academy of Sciences, India, the Indian National Science Academy and the Indian Academy of Sciences. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences, in 2011.

Gregory James Hannon is a professor of molecular cancer biology and director of the Cancer Research UK Cambridge Institute at the University of Cambridge. He is a Fellow of Trinity College, Cambridge while also serving as a director of cancer genomics at the New York Genome Center and an adjunct professor at Cold Spring Harbor Laboratory.

Dafna Bar-Sagi is a cell biologist and cancer researcher at New York University School of Medicine. She is the Saul J. Farber Professor in the department of biochemistry and molecular pharmacology and the department of medicine and senior vice president and vice dean for science at NYU Langone Health. Bar-Sagi has been a member of scientific advisory boards, including the National Cancer Institute, Starr Cancer Consortium, and Pancreatic Cancer Action Network.

Guillermina 'Gigi' Lozano is an American geneticist. She is a professor at University of Texas MD Anderson Cancer Center. Lozano is recognised for her studies of the p53 tumour suppressor pathway, characterising the protein as a regulator of gene expression.

Eileen White is an American professor and scientist who currently serves as deputy director, chief scientific officer, and associate director for basic science at the Rutgers Cancer Institute of New Jersey. She is also the distinguished professor of molecular biology and biochemistry at Rutgers University. White was elected member of the National Academy of Sciences in 2021.

<span class="mw-page-title-main">Yardena Samuels</span> Israeli molecular biologist

Yardena Samuels or Samuels-Lev is an Israeli molecular biologist who is the Director of the Ekard Institute for Cancer Diagnosis Research at the Weizmann Institute of Science. Her research considers the genetic mutations of melanoma.

Laura Attardi is the Catharine and Howard Avery Professor of the school of medicine, and professor of radiation oncology and genetics at Stanford University where she leads the Attardi Laboratory. Attardi studies the tumor suppressor protein p53 and the gene that encodes it, TP53, to better understand mechanisms for preventing cancer.

Lisa M. Coussens is an American cancer scientist who is Chair of the Department of Cell, Developmental and Cancer Biology and Professor and Associate Director for Basic Research in the Knight Cancer Institute at the Oregon Health & Science University. She serves as President of the American Association for Cancer Research.

References

  1. 1 2 3 "Carol L. Prives, PhD - AACR International". www.aacrcanada.ca.
  2. ↑ Prives, Carole. "The biosynthesis of nucleotides and nucleic acis in Ehrlich ascites cells and the effect of colchicine thereon". escholarship.mcgill.ca. C. (Supervisor) Sung. Retrieved 2020-08-16.
  3. 1 2 3 4 "Carol L. Prives, PhD".
  4. ↑ "Carol L. Prives Ph.D.: Executive Profile & Biography - Bloomberg". www.bloomberg.com. 28 September 2023.
  5. ↑ Phone: 514 398-6751, Contact Information Contact: Julie Fortier Organization: Media Relations Office Email: julie c fortiermcgill ca Office. "14 individuals to receive honorary degree from McGill". Newsroom. Retrieved 2020-08-16.
  6. 1 2 "Prof. Carol Prives | International Board 2018". www.weizmann.ac.il. Retrieved 3 May 2019.
  7. ↑ "Carol Prives". www.nasonline.org. Retrieved 2020-08-16.
  8. ↑ "Editorial board: Cell".
  9. ↑ "Editorial Board - Oncogene". www.nature.com.
  10. ↑ "PNAS Member Editor Details". nrc88.nas.edu. Retrieved 3 May 2019.
  11. ↑ "Carol Prives". www.nasonline.org.
  12. ↑ "Past Winners of the NCI Rosalind E. Franklin Award - National Cancer Institute". dceg.cancer.gov. 2017-02-06. Retrieved 2020-08-16.
  13. ↑ "Carol Prives FRS, Royal Society".
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.